MS drug alters B cell metabolism
- PMID: 35379952
- DOI: 10.1038/s41582-022-00655-4
MS drug alters B cell metabolism
Comment on
-
BTK inhibition limits B-cell-T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy.Acta Neuropathol. 2022 Apr;143(4):505-521. doi: 10.1007/s00401-022-02411-w. Epub 2022 Mar 18. Acta Neuropathol. 2022. PMID: 35303161 Free PMC article.
References
Original article
-
- Li, R. et al. BTK inhibition limits B-cell–T-cell interaction through modulation of B-cell metabolism: implications for multiple sclerosis therapy. Acta Neuropathol. https://doi.org/10.1007/s00401-022-02411-w (2022) - DOI - PubMed - PMC
Publication types
LinkOut - more resources
Full Text Sources